Orexigen Therapeutics Ireland Limited

Orexigen Therapeutics Ireland Limited is the European marketing authorisation holder for Mysimba (naltrexone/bupropion prolonged-release tablets), licensed in the UK for chronic weight management in obese or overweight adults with weight-related comorbidities. Mysimba is distributed in the UK through Consilient Health Ltd. The company is a subsidiary of the Currax Pharmaceuticals group.